Clinical Trial: Comparison of Aspirin Alone Versus Low-Dose Rivaroxaban Plus Aspirin in Chronic Limb-Threatening Ischemia

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07832578) titled 'Comparison of Aspirin Alone Versus Low-Dose Rivaroxaban Plus Aspirin in Chronic Limb-Threatening Ischemia' on Sept. 07.

Brief Summary: The goal of this **clinical trial** is to compare the effectiveness of **low-dose rivaroxaban plus aspirin versus aspirin alone** in patients aged 40-70 years with **chronic limb-threatening ischemia, diabetes mellitus, hypertension, and hypercholesterolemia**. The main questions it aims to answer are:

* Does low-dose rivaroxaban plus aspirin reduce **major adverse limb events (MALE)**, such as acute limb ischemia and amputation?

* Does the combination therapy reduce **major adverse cardiovascular...